Rxbiologics
Antibody discovery services for biologics drug discovery programmes, built on a proprietary human antibody library
Highlights
- New on EvolcAdded 2026-10-30
About Rxbiologics
RxBiologics provides antibody drug discovery services using its proprietary Galaxy® antibody library and display platform. Services cover reagent generation, lead isolation, antibody humanisation and optimisation, in silico antibody analysis, antibody reformatting and production, and rapid production of multi-specific antibodies. The Galaxy® library technology was invented by co-founder Jonny Finlay.
The company works with clients and partners on bespoke discovery programmes, from early discovery through preclinical phases. The Galaxy® library is offered to clients and partners on a license-free, open-access basis. RxBiologics is part of the RxCelerate Group, which provides drug discovery and development services for small molecules and biologics.
RxCelerate was founded in 2013, and RxBiologics was founded in 2017. The company is headquartered in Cambridge, United Kingdom. Its leadership team includes co-founders David Grainger (Executive Chairman), Jill Reckless and Jonny Finlay, and its Scientific Advisory Board is chaired by Jonny Finlay.
Product: Galaxy® antibody library and display platform, with antibody discovery, humanisation, reformatting, production and in silico analysis services.
Jobs at Rxbiologics
Leadership
- David Grainger · Co-founder & Executive ChairmanSource: company website
- Jill Reckless · Co-founder & DirectorSource: company website
- Jonny Finlay · Co-founder & DirectorSource: company website
- Nick Tait · CFOSource: company website
More biotech & pharma companies
Scancell
Clinical-stage immunotherapy developer for difficult-to-treat cancers, using Immunobody and Moditope platformsNew on EvolcScripta Therapeutics
Drug discovery platform using transcription factor mapping and AI models to find neurodegenerative disease therapiesYoung companyNew on EvolcSisaf
RNA drug-delivery platform licensed to pharma partners, with a research reagent for labs plannedNew on EvolcSitala Bio
Develops medicines targeting harmful inflammation for patients with neurodegenerative and inflammatory diseasesNew on EvolcSmartway Pharmaceuticals
Pharmaceutical wholesaling and specialist medicine supply for healthcare providers, pharmaceutical companies and aid organizationsNew on EvolcSolasta Bio
Develops peptide-based precision insecticides for growers and agricultural businesses seeking crop protectionNew on Evolc
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Azure
- Cloudflare
- Google Analytics 4
- Iubenda
- WooCommerce
- WordPress
- jQuery
